Since identifying the cybersecurity incident on August 25, Boston Scientific has worked closely with CrowdStrike and other third-party cybersecurity experts to contain the threat, conduct a ...
Chronic pain is often misunderstood, underdiagnosed and undertreated. Today, new treatment options are helping more people find relief.
To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income ...
"Our team delivered a solid quarter while continuing to navigate a dynamic environment," says Mike Mahoney, chairman and chief executive officer, Boston Scientific. "We are focused on disciplined ...
For millions of people living with overactive bladder (OAB), daily life can revolve around one constant question: Where’s the nearest bathroom? OAB can create sudden, frequent urges to urinate that ...
Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease Moderate-to-severe ...
MARLBOROUGH, Mass., May 18, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase ...
MARLBOROUGH, Mass., May 18, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has invested $1.5 billion in return for an approximately 34% equity stake in MiRus LLC, a ...
Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions The randomized AVANT GUARD clinical ...
MARLBOROUGH, Mass., April 22, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.203 billion during the first quarter of 2026, growing 11.6 percent on a reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results